clinician – Page 20 – Communicable Diseases Research

COVID-19 mRNA Vaccine-Associated Myocarditis

Cardiology

Published on 2022-01-072022-10-31
Journal: Cureus [Category] COVID-19,

Not Only High Number and Specific Comorbidities but Also Age Are Closely Related to Progression and Poor Prognosis in Patients With COVID-19

Medicine

Published on 2022-01-072022-10-31
Journal: Frontiers in Medicine [Category] COVID-19,

[키워드] age cardiovascular disease Characteristics CHB Chinese Chronic Hepatitis B Chronic kidney disease chronic obstructive CKD clinical clinician Comorbidities Comorbidity COPD Coronavirus disease 2019 (COVID-19) correlated correlation Correlation analysis COVID-19 COVID-19 patient COVID-19 patients CVD Diabetes Mellitus died disease Disease progression disease severity eight Factor Fatty liver FIVE Gout group groups hypertension NAFLD Negative conversion number number of comorbidities number of comorbidity Older outcome outcomes patients with comorbidity patients with COVID-19 Poor poor prognosis predict Predictive Prognosis progression pulmonary disease severe COVID-19 patients Specific virus were assessed
[DOI] 10.3389/fmed.2021.736109 PMC 바로가기 [Article Type] Medicine

The Impact of COVID-19 on the Delivery of Systemic Anti-Cancer Treatment at Guy’s Cancer Centre

Article

Published on 2022-01-062022-10-31
Journal: Cancers [Category] COVID-19,

[키워드] anti-cancer treatment can be used Cancer cancer patient cancer treatment Chemotherapy clinician Cohort collected comparable COVID-19 COVID-19 infection COVID-19 pandemic death rate decrease delivery demographics disease expected First wave help Immunotherapy Impact increase in increased risk infections Mortality oncology outcome pandemic Patient patients Prevalence real-world data receiving reduction in reflect SACT SARS-COV-2 infection SARS-CoV2 SARS-CoV2 infection Severe COVID-19 Infection significant effect significant increase significantly simple solid tumour subsequent Symptom systemic Systemic anti-cancer treatment Treatment vulnerable patients worsening
[DOI] 10.3390/cancers14020266 PMC 바로가기 [Article Type] Article

Pandemic-related declines in hospitalization for non-COVID-19-related illness in the United States from January through July 2020

Research Article

Published on 2022-01-062022-10-28
Journal: PLoS ONE [Category] COVID-19,

Double-blind placebo-controlled randomized clinical trial to assess the efficacy of montelukast in mild to moderate respiratory symptoms of patients with long COVID: E-SPERANZA COVID Project study protocol

장기간 COVID-19 환자의 경증에서 중등도의 호흡기 증상에 대한 몬테루카스트의 효능을 평가하기 위한 이중 맹검 위약 대조 무작위 임상 시험: E-SPERANZA COVID 프로젝트 연구 프로토콜

Study Protocol

Published on 2022-01-062022-09-10
Journal: Trials [Category] SARS, 임상,

[키워드] 1:1 acute phase Affect Ageusia Analysis Anosmia approved assessment asthenia Awareness Brain Clinical research clinical trial clinician Confusion control group COPD coronavirus disease Coronavirus disease 2019 COVID COVID-19 COVID-19 symptom COVID-19 symptoms defined Desaturation disabling symptoms dissemination double-blind Dyspnea effective Efficacy Ethics ethics committee EudraCT evaluate evaluate the effect Exercise capacity exertion explained functional Functional status globe headache Health Health status healthcare include Infection Intervention life Likert scale Long COVID Mental mental confusion Mild mild to moderate moderate Montelukast Mortality objective Open Access oxygen oxygen saturation pandemic participant pathophysiology Patient patients with SARS-CoV-2 peer-reviewed phase Placebo placebo group placebo-controlled primary care Primary outcome professionals Quality of life questionnaire Randomized randomized clinical trial Randomized controlled trial Randomly reference number Registered Research Ethics respiratory respiratory symptom respiratory symptoms SARS-CoV-2 SARS-COV-2 infection Secondary objectives Secondary outcomes sick Side effect Study protocol subgroup of patient Test the SARS-CoV-2 Treatment Trial Trial registration while
[DOI] 10.1186/s13063-021-05951-w PMC 바로가기 [Article Type] Study Protocol

A post pandemic roadmap toward remote assessment for neuromuscular disorders: limitations and opportunities

Position Statement

Published on 2022-01-042022-10-29
Journal: Orphanet Journal of Rare Diseases [Category] Coronavirus, SARS,

Disease characteristics and serological responses in patients with differing severity of COVID-19 infection: A longitudinal cohort study in Dhaka, Bangladesh

COVID-19 감염의 중증도가 다른 환자의 질병 특성 및 혈청 반응: 방글라데시 다카의 종단 코호트 연구

Research Article

Published on 2022-01-042022-09-12
Journal: PLoS Neglected Tropical Diseases [Category] 진단,

[키워드] addition age age and sex analyzed antibody Antibody Response antibody response against Antibody responses Asymptomatic asymptomatic infection asymptomatic infections biochemical caused Characteristics clinician co-morbid condition co-morbid conditions Community conducted Control COVID-19 COVID-19 disease COVID-19 illness COVID-19 infection CRP CRP level CRP levels D-dimer disease disease severity Disease spectrum elevated enrolled Enrollment evaluate exclusion criteria ferritin ferritin level ferritin levels Follow-up visit follow-up visits Gender geographical region healthy healthy controls help hematological parameter hematological parameters hospital IgG antibodies IgG antibody IgG levels IgM and IgG immunological parameter immunological parameters infected individual Infection levels of antibody longitudinal cohort study longitudinal study lymphocyte lymphocyte counts male many cases Mild Mild disease moderate neutrophil neutrophil count NLR normal range Older age onset of symptom outcome outcomes participant Patient patients patients with COVID-19 predict progression RBD Receptor binding domain responsible risk factor Risk factors SARS-CoV-2 serological response seropositive Severe case severe cases severe COVID-19 disease severe COVID-19 illness severe disease severe disease manifestation severe patients severity of COVID-19 significantly higher Spike protein spike protein of SARS-CoV-2 the disease the spike protein Viral load
[DOI] 10.1371/journal.pntd.0010102 PMC 바로가기 [Article Type] Research Article

Axillary Lymphadenopathy on Ultrasound after COVID-19 Vaccination and Its Influencing Factors: A Single-Center Study

Article

Published on 2022-01-032022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Propolis and Diet Rich in Polyphenols as Cariostatic Agents Reducing Accumulation of Dental Plaque

Review

Published on 2022-01-022022-10-30
Journal: Molecules [Category] COVID-19,

Synergistic Action of Immunotherapy and Nanotherapy against Cancer Patients Infected with SARS-CoV-2 and the Use of Artificial Intelligence

Review

Published on 2022-01-022022-10-31
Journal: Cancers [Category] COVID-19,

[키워드] Action adopted Alter approach artificial artificial intelligence Cancer cancer patient caused Chemotherapy Clinical characteristics clinician Combination diagnosed early stage Efficacy healthcare Immune checkpoint inhibitor immune response Immunotherapy IMPROVE individual infected with SARS-CoV-2 Infection intelligence modify MONITOR mortality rate nanotherapy oncologist pandemic Patient patients physician predict problem Radiotherapy real time reduce risk SARS-CoV-2 severity simple susceptible the patient the SARS-CoV-2 therapy treat Treatment Vaccine virus vulnerable patients weakened
[DOI] 10.3390/cancers14010213 PMC 바로가기 [Article Type] Review